NCT07828028

Brief Summary

This study aims to determine the effects of the 4-7-8 breathing technique on anxiety, symptom severity, and sleep quality during treatment. A randomized controlled trial design was employed, involving 64 participants (intervention group: n=32; control group: n=32) undergoing their third treatment cycle. The intervention group received the 4-7-8 breathing technique twice daily for 21 days in addition to routine care, while the control group received routine care and standard supportive care. Data will be collected at pre-test and post-test stages using the Descriptive Information Form, the State-Trait Anxiety Inventory (STAI-State), the Edmonton Symptom Assessment System (ESAS), and the Pittsburgh Sleep Quality Index (PSQI). Data analysis will be performed using the SPSS 22.0 software.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 14, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 18, 2026

Completed
Last Updated

September 23, 2026

Status Verified

September 1, 2026

Enrollment Period

1.3 years

First QC Date

September 14, 2026

Last Update Submit

September 18, 2026

Conditions

Keywords

4-7-8 breathing techniquechemotherapysymptom burdensleep qualityanxietycanceroncology nursing

Outcome Measures

Primary Outcomes (3)

  • State Anxiety Level

    State anxiety level was assessed using the State-Trait Anxiety Inventory-State subscale (STAI-S). The STAI-S consists of 20 items, with total scores ranging from 20 to 80. Higher scores indicate higher levels of state anxiety. State anxiety was assessed at baseline and on Day 21.

    Baseline and Day 21

  • Sleep Quality

    Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). The PSQI evaluates subjective sleep quality and sleep disturbances, with higher total scores indicating poorer sleep quality. Sleep quality was assessed at baseline and on Day 21.

    Baseline and Day 21

  • Chemotherapy Symptom Burden

    Chemotherapy symptom burden was assessed using the Edmonton Symptom Assessment System (ESAS). The severity of symptoms was rated on a 0-10 numerical scale, with higher scores indicating greater symptom severity. Chemotherapy symptom burden was assessed at baseline and on Day 21.

    Baseline and Day 21

Study Arms (2)

4-7-8 Breathing Technique

EXPERIMENTAL

Participants receiving the 3rd cycle of chemotherapy will be assigned to the intervention group. Participants will receive routine nursing care and standard chemotherapy care in addition to the 4-7-8 breathing technique. The breathing technique will be individually taught face-to-face by the researcher before chemotherapy. Participants will perform the technique twice daily, in the morning and evening, for 21 consecutive days. Each session will consist of four cycles of the 4-7-8 breathing technique. Assessments will be performed at baseline and on the 21st day to evaluate anxiety, chemotherapy symptom burden, and sleep quality.

Behavioral: 4-7-8 breathing techniqueOther: routine care

Routine Care

ACTIVE COMPARATOR

Participants receiving the 3rd cycle of chemotherapy will be assigned to the control group. Participants will receive routine nursing care and standard chemotherapy care according to usual clinical practice. The 4-7-8 breathing technique will not be provided during the 21-day study period. Assessments will be performed at baseline and on the 21st day to evaluate anxiety, chemotherapy symptom burden, and sleep quality.

Other: routine care

Interventions

Participants in the intervention group will receive routine chemotherapy care in addition to the 4-7-8 breathing technique. The technique will be taught individually by the researcher face-to-face before chemotherapy. Participants will perform the technique twice daily, once in the morning and once in the evening, for 21 consecutive days. Each session will consist of four cycles of the 4-7-8 breathing technique.

4-7-8 Breathing Technique

Participants in the control group will receive routine nursing care and standard chemotherapy care according to the usual clinical practice. No 4-7-8 breathing technique will be provided during the study period.

4-7-8 Breathing TechniqueRoutine Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Requirements include being 18 years of age or older;
  • not being in the third stage of the disease;
  • having no communication barriers, mental or physical impairments, or visual or hearing impairments;
  • being able to speak Turkish and agreeing to participate.

You may not qualify if:

  • Those who do not agree to participate in the study,
  • Those under the age of 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziantep City Hospital

Gaziantep, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersAnxiety DisordersNeoplasms

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nurse

Study Record Dates

First Submitted

September 14, 2026

First Posted

September 18, 2026

Study Start

March 15, 2025

Primary Completion

June 25, 2026

Study Completion

June 25, 2026

Last Updated

September 23, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to patient privacy and confidentiality concerns. The data are collected within a single institutional clinical study for academic thesis purposes and are not planned for public data sharing.

Locations